Leukemia issue (16 Ergebnisse)

hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Hardcover. Zustand: As New. Tight, unread copy with sharp corners. No marks. Unused.

Zustand: Good Condition. Published by the American Medical Association.

Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp. Englisch. …

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This issue concentrates on the current evidence and the collected experience of pediatric oncologists who care for cancer patients. The individual articles will provide the general pediatrician with a comprehensive primer on diagnosing and managing various types of cancers in the child with cancer. A cancer diagnosis is no longer a death sentence, so management and monitoring is very important and covered in every article. Englisch.…

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This issue of Hematology/Oncology Clinics is edited by Dr. Jennifer Brown and focuses on Chronic Lymphocytic Leukemia. Article topics include: What Have Recent Genomic Advances Taught us About CLL , Biology of CLL in Different Microenvironments,What is the Significance of Stereotyped BCRs in CLL , Understanding Immunodeficiency in CLL, MBL vs CLL: How Important is the Distinction , Risk Stratification of CLL in 2012, Minimal Residual Disease Measurement in CLL, The BTK Inhibitor PCI-32765 in CLL, and Evolving Role of Stem Cell Transplantation in CLL. 380 pp. Englisch.…

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL ; What does the status of ZAP-70 tell us about the biology of CLL ; and Approach to initial therapy: When to start therapy Englisch.…

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why ; Chronic Myeloid Leukemia - Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome. Englisch.…

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown_, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet ; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy ; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia ; and Immune Therapy for Chronic Lymphocytic Leukemia 240 pp. Englisch. …

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This issue concentrates on the current evidence and the collected experience of pediatric oncologists who care for cancer patients. The individual articles will provide the general pediatrician with a comprehensive primer on diagnosing and managing various types of cancers in the child with cancer. A cancer diagnosis is no longer a death sentence, so management and monitoring is very important and covered in every article.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why ; Chronic Myeloid Leukemia - Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This issue of Hematology/Oncology Clinics is edited by Dr. Jennifer Brown and focuses on Chronic Lymphocytic Leukemia. Article topics include: What Have Recent Genomic Advances Taught us About CLL , Biology of CLL in Different Microenvironments,What is the Significance of Stereotyped BCRs in CLL , Understanding Immunodeficiency in CLL, MBL vs CLL: How Important is the Distinction , Risk Stratification of CLL in 2012, Minimal Residual Disease Measurement in CLL, The BTK Inhibitor PCI-32765 in CLL, and Evolving Role of Stem Cell Transplantation in CLL.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL ; What does the status of ZAP-70 tell us about the biology of CLL ; and Approach to initial therapy: When to start therapy.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown_, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet ; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy ; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia ; and Immune Therapy for Chronic Lymphocytic Leukemia.…